Global Pharma Contract Sales Market 2017-2027

NEW YORK, July 31, 2017 /PRNewswire/ -- Report Details
The global pharma contract sales market is expected to grow at a CAGR of 10.5% in the first half of the forecast period. The market is expected to grow at a CAGR of 9.5% from 2016-2027. The market is estimated at $4.9bn in 2016 and $8.09bn in 2021.

Read the full report: http://www.reportlinker.com/p05028030/Global-Pharma-Contract-Sales-Market.html

How this report will benefit you

Read on to discover how you can exploit the future business opportunities emerging in this sector.

In this brand new 260-page report you will receive 95 tables and 65 figures– all unavailable elsewhere.

The 260-page report provides clear detailed insight into the global pharma contract sales market. Discover the key drivers and challenges affecting the market.

By ordering and reading our brand new report today you stay better informed and ready to act.

Report Scope
• Global Pharma Contract Sales Market forecasts from 2017-2027

• Along with revenue prediction for the overall world market for pharma contract sales market, our investigation shows forecasts to 2027 for the following submarkets:
- Contract detailing (personal promotion/field sales)
- Contract non-personal promotion, with further sub-forecasting for teledetailing, eDetailing and others
- Medical education services
- Sample management services

• This report also breaks down the revenue forecast for pharma contract sales market by therapeutic segments:
- Cardiovascular disease
- Metabolic disorders
- Cancer treatment
- Other

• This report provides individual revenue forecasts to 2027 for these regional and national markets:
- USA
- Japan
- Germany, UK, France, Italy and Spain (EU5 countries)
- China, India, Brazil and Russia (BRIC group)

• Our study discusses the SWOT and STEP factors of the global pharma contract sales market

• Our study discusses issues affecting the pharma contract sales industry and market from 2016:
- Outsourced and in-house sales reps – trends and emerging sales models, including multiple channels (multichannel marketing to medical professionals)
- Services CSOs offer and benefits to drug companies outsourcing medical sales
- Maturing brands and product launches, including flexibility in field sales teams
- Legislation and new market access requirements for pharma sales representatives
- Changes to online marketing and potential for IT technologies Risk-sharing agreements
Read the full report: http://www.reportlinker.com/p05028030/Global-Pharma-Contract-Sales-Market.html

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

http://www.reportlinker.com

__________________________
Contact Clare: clare@reportlinker.com
US: (339)-368-6001
Intl: +1 339-368-6001

View original content:http://www.prnewswire.com/news-releases/global-pharma-contract-sales-market-2017-2027-300496887.html

SOURCE Reportlinker